All Stories

  1. Extracellular vesicles: A new frontier in the theranostics of cardiovascular diseases
  2. Off-the-shelf GMP-grade UC-MSCs as therapeutic drugs for the amelioration of CCl4-induced acute-on-chronic liver failure in NOD-SCID mice
  3. The RGD-modified self-assembling D-form peptide hydrogel enhances the therapeutic effects of mesenchymal stem cells (MSC) for hindlimb ischemia by promoting angiogenesis
  4. Advances and Perspectives of Pharmaceutical Nanotechnology in mRNA therapy
  5. Therapeutic application of tumour cell‐derived extracellular vesicles for drug‐resistant cancer therapy via interleukin 6/signal transducer and activator of transcription 3 signalling pathway
  6. Intravenously transplanted mesenchymal stromal cells: a new endocrine reservoir for cardioprotection
  7. Nitric oxide improves regeneration and prevents calcification in bio-hybrid vascular grafts via regulation of vascular stem/progenitor cells
  8. A supramolecular hydrogel based on the combination of YIGSR and RGD enhances mesenchymal stem cells paracrine function via integrin α2β1 and PI3K/AKT signaling pathway for acute kidney injury therapy
  9. Dppa3 facilitates self-renewal of embryonic stem cells by stabilization of pluripotent factors
  10. Anti-inflammatory Effects of Mesenchymal Stem Cells and their Secretomes in Pneumonia
  11. Comparison of the treatment efficacy of umbilical mesenchymal stem cell transplantation via renal subcapsular and parenchymal routes in AKI-CKD mice
  12. The sustained PGE2 release matrix improves neovascularization and skeletal muscle regeneration in a hindlimb ischemia model
  13. Editorial
  14. Renal subcapsular delivery of PGE2 promotes kidney repair by activating endogenous Sox9+ stem cells
  15. Mesenchymal Stem Cell-Derived Extracellular Vesicles Attenuate Radiation-Induced Lung Injury via miRNA-214-3p
  16. Embryonic stem cell-derived extracellular vesicles promote the recovery of kidney injury
  17. Meet the Editor-in-Chief
  18. Intravital microscopy imaging of kidney injury and regeneration
  19. CD73+ Mesenchymal Stem Cells Ameliorate Myocardial Infarction by Promoting Angiogenesis
  20. Chitosan hydrogel-loaded MSC-derived extracellular vesicles promote skin rejuvenation by ameliorating the senescence of dermal fibroblasts
  21. Isolation and Multiple Differentiation of Rat Pericardial Fluid Cells
  22. Intranasal delivery of MSC-derived exosomes attenuates allergic asthma via expanding IL-10 producing lung interstitial macrophages in mice
  23. The delivery of hsa-miR-11401 by extracellular vesicles can relieve doxorubicin-induced mesenchymal stem cell apoptosis
  24. Applications of Decellularized Extracellular Matrix for Regenerative Medicine
  25. Arf6-mediated macropinocytosis-enhanced suicide gene therapy of C16TAB-condensed Tat/pDNA nanoparticles in ovarian cancer
  26. Extracellular vesicles derived from human placental mesenchymal stem cells alleviate experimental colitis in�mice by inhibiting inflammation and oxidative stress
  27. <p>Delivery of MSCs with a Hybrid β-Sheet Peptide Hydrogel Consisting IGF-1C Domain and D-Form Peptide for Acute Kidney Injury Therapy</p>
  28. Correction to: IGF-1C domain–modified hydrogel enhanced the efficacy of stem cells in the treatment of AMI
  29. Enhanced therapeutic effects of MSC-derived extracellular vesicles with an injectable collagen matrix for experimental acute kidney injury treatment
  30. In Vivo Tracking of Mesenchymal Stem Cell-Derived Extracellular Vesicles Improving Mitochondrial Function in Renal Ischemia–Reperfusion Injury
  31. IGF-1C domain–modified hydrogel enhanced the efficacy of stem cells in the treatment of AMI
  32. IGF-1C hydrogel improves the therapeutic effects of MSCs on colitis in mice through PGE2-mediated M2 macrophage polarization
  33. Mesenchymal Stem Cell-Derived Extracellular Vesicles for Corneal Wound Repair
  34. The Application of Methylprednisolone Nanoscale Zirconium-Porphyrin Metal-Organic Framework (MPS-NPMOF) in the Treatment of Photoreceptor Degeneration
  35. Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease
  36. Nitric‐Oxide‐Releasing Biomaterial Regulation of the Stem Cell Microenvironment in Regenerative Medicine
  37. Dual Bioluminescence Imaging of Tumor Progression and Angiogenesis
  38. The role of biomaterials in stem cell-based regenerative medicine
  39. JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia
  40. MSC-derived sEVs enhance patency and inhibit calcification of synthetic vascular grafts by immunomodulation in a rat model of hyperlipidemia
  41. IGF-1C domain-modified hydrogel enhances therapeutic potential of mesenchymal stem cells for hindlimb ischemia
  42. In Vivo Real-Time Imaging of Extracellular Vesicles in Liver Regeneration via Aggregation-Induced Emission Luminogens
  43. Self-assembled GFFYK peptide hydrogel enhances the therapeutic efficacy of mesenchymal stem cells in a mouse hindlimb ischemia model
  44. Molecular Imaging of Therapeutic Effect of Mesenchymal Stem Cell-Derived Exosomes for Hindlimb Ischemia Treatment
  45. Embryonic stem cell-derived extracellular vesicles enhance the therapeutic effect of mesenchymal stem cells
  46. Introduction of Perinatal Tissue-Derived Stem Cells
  47. Perinatal Stem Cells in Kidney Regeneration: Current Knowledge and Perspectives
  48. Proangiogenic Features of Perinatal Tissue-Derived Stem Cells in Cardiovascular Disease Therapy
  49. Perinatal Stem Cells
  50. Folic acid-nanoscale gadolinium-porphyrin metal-organic frameworks: fluorescence and magnetic resonance dual-modality imaging and photodynamic therapy in hepatocellular carcinoma
  51. Dppa3 is critical for Lin28a-regulated ES cells naïve–primed state conversion
  52. Dppa3 in pluripotency maintenance of ES cells and early embryogenesis
  53. MSCs inhibit tumor progression and enhance radiosensitivity of breast cancer cells by down-regulating Stat3 signaling pathway
  54. Stat3 activation is critical for pluripotency maintenance
  55. Enhanced Therapeutic Effects of Mesenchymal Stem Cell-Derived Exosomes with an Injectable Hydrogel for Hindlimb Ischemia Treatment
  56. Directed Differentiation of Human Corneal Endothelial Cells From Human Embryonic Stem Cells by Using Cell-Conditioned Culture Media
  57. Intravenous injection of allogeneic umbilical cord-derived multipotent mesenchymal stromal cells reduces the infarct area and ameliorates cardiac function in a porcine model of acute myocardial infarction
  58. Current View on Hematopoiesis and Beyond
  59. Comparison of Teratoma Formation between Embryonic Stem Cells and Parthenogenetic Embryonic Stem Cells by Molecular Imaging
  60. VE-Cadherin regulates the self-renewal of mouse embryonic stem cells via LIF/Stat3 signaling pathway
  61. Knockout of zebrafish interleukin 7 receptor (IL7R) by the CRISPR/Cas9 system delays retinal neurodevelopment
  62. Exosomes from mesenchymal stromal cells enhance imatinib-induced apoptosis in human leukemia cells via activation of caspase signaling pathway
  63. Inflammatory Human Umbilical Cord-Derived Mesenchymal Stem Cells Promote Stem Cell-Like Characteristics of Cancer Cells in an IL-1β-Dependent Manner
  64. Hydrogel-Based Strategies for Stem Cell Therapy
  65. Prostaglandin E2 hydrogel improves cutaneous wound healing via M2 macrophages polarization
  66. Nitric oxide releasing hydrogel promotes endothelial differentiation of mouse embryonic stem cells
  67. A macroporous heparin-releasing silk fibroin scaffold improves islet transplantation outcome by promoting islet revascularisation and survival
  68. Molecular Imaging of Tumor Angiogenesis and Therapeutic Effects with Dual Bioluminescence
  69. Enhanced proangiogenic potential of mesenchymal stem cell-derived exosomes stimulated by a nitric oxide releasing polymer
  70. Down-regulation of interleukin 7 receptor (IL-7R) contributes to central nervous system demyelination
  71. Stat3 phosphorylation is required for embryonic stem cells ground state maintenance in 2i culture media
  72. Three structurally related Copper complexes with two isomers: DNA/BSA binding ability, DNA cleavage activity and excellent cytotoxicity
  73. Transplantation of Human Placenta-Derived Mesenchymal Stem Cells Alleviates Critical Limb Ischemia in Diabetic Nude Rats
  74. Molecular Imaging of Inducible VEGF Expression and Tumor Progression in a Breast Cancer Model
  75. LMO2 promotes tumor cell invasion and metastasis in basal-type breast cancer by altering actin cytoskeleton remodeling
  76. Meet Our Editorial Board Member
  77. Heterogeneity of proangiogenic features in mesenchymal stem cells derived from bone marrow, adipose tissue, umbilical cord, and placenta
  78. Increased complements and high-sensitivity C-reactive protein predict heart failure in acute myocardial infarction
  79. LMO2 attenuates tumor growth by targeting the Wnt signaling pathway in breast and colorectal cancer
  80. Interferon-γ alters the microRNA profile of umbilical cord-derived mesenchymal stem cells
  81. Erratum: Bone Marrow Mesenchymal Stem Cells (BM-MSCs) Improve Heart Function in Swine Myocardial Infarction Model through Paracrine Effects
  82. Embryonic stem cell preconditioned microenvironment suppresses tumorigenic properties in breast cancer
  83. Bone Marrow Is a Reservoir for Cardiac Resident Stem Cells
  84. Bone Marrow Mesenchymal Stem Cells (BM-MSCs) Improve Heart Function in Swine Myocardial Infarction Model through Paracrine Effects
  85. Copper complexes based on chiral Schiff-base ligands: DNA/BSA binding ability, DNA cleavage activity, cytotoxicity and mechanism of apoptosis
  86. VCAM-1+ placenta chorionic villi-derived mesenchymal stem cells display potent pro-angiogenic activity
  87. Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects
  88. IGF-1 C Domain–Modified Hydrogel Enhances Cell Therapy for AKI
  89. Identification of Stem-Like Cells in Atrial Myxoma by Markers CD44, CD19, and CD45
  90. Proangiogenic Features of Mesenchymal Stem Cells and Their Therapeutic Applications
  91. Controlled nitric oxide release for tissue repair and regeneration
  92. Translational applications of molecular imaging in cardiovascular disease and stem cell therapy
  93. Nitric oxide releasing hydrogel enhances the therapeutic efficacy of mesenchymal stem cells for myocardial infarction
  94. Extracellular Matrix can Recover the Downregulation of Adhesion Molecules after Cell Detachment and Enhance Endothelial Cell Engraftment
  95. Gene and MicroRNA Profiling of Human Induced Pluripotent Stem Cell-Derived Endothelial Cells
  96. Activating Transcription Factor 4 Promotes Angiogenesis of Breast Cancer through Enhanced Macrophage Recruitment
  97. Angiogenesis
  98. Molecular Imaging: The Key to Advancing Stem Cell Therapy
  99. OSM Enhances Angiogenesis and Improves Cardiac Function after Myocardial Infarction
  100. Differential effects of tumor necrosis factor-α on matrix metalloproteinase-2 expression in human myometrial and uterine leiomyoma smooth muscle cells
  101. Differential expression of caveolin-1 in human myometrial and uterine leiomyoma smooth muscle
  102. Phase dependent luminescent property of N,N-di(n-octyl)quinacridone crystals
  103. IFN-γ mediates graft-versus-breast cancer effects via enhancing cytotoxic T lymphocyte activity
  104. Molecular imaging for assessment of mesenchymal stem cells mediated breast cancer therapy
  105. Synthesis, Biodistribution, and Imaging of PEGylated-Acetylated Polyamidoamine Dendrimers
  106. Tumor necrosis factor-α regulates matrix metalloproteinase-2 expression and cell migration via ERK pathway in rat glomerular mesangial cells
  107. Bone Marrow Vascular Niche: Home for Hematopoietic Stem Cells
  108. Nanoparticle-Based Tumor Theranostics with Molecular Imaging
  109. The role of Hath6, a newly identified shear-stress-responsive transcription factor, in endothelial cell differentiation and function
  110. Human Embryonic Stem Cell-Derived Endothelial Cells as Cellular Delivery Vehicles for Treatment of Metastatic Breast Cancer
  111. Noninvasive Imaging of Hypoxia-Inducible Factor-1α Gene Therapy for Myocardial Ischemia
  112. Yes-associated protein (YAP) increases chemosensitivity of hepatocellular carcinoma cells by modulation of p53
  113. Human embryonic stem cells-derived endothelial cell therapy facilitates kidney regeneration by stimulating renal resident stem cell proliferation in acute kidney injury
  114. Imaging Neural Stem Cell Graft-Induced Structural Repair in Stroke
  115. The Phenotypic Fate of Bone Marrow-Derived Stem Cells in Acute Kidney Injury
  116. Bioluminescence Imaging of Human Embryonic Stem Cell-Derived Endothelial Cells for Treatment of Myocardial Infarction
  117. Transplantation of parthenogenetic embryonic stem cells ameliorates cardiac dysfunction and remodelling after myocardial infarction
  118. Assessment of Therapeutic Efficacy of Liposomal Nanoparticles Mediated Gene Delivery by Molecular Imaging for Cancer Therapy
  119. Bone marrow-derived cells can acquire renal stem cells properties and ameliorate ischemia-reperfusion induced acute renal injury
  120. Improved mesenchymal stem cell survival in ischemic heart through electroacupuncture
  121. CD44 antibody-targeted liposomal nanoparticles for molecular imaging and therapy of hepatocellular carcinoma
  122. Legumain: A biomarker for diagnosis and prognosis of human ovarian cancer
  123. Fra-1 Promotes Breast Cancer Chemosensitivity by Driving Cancer Stem Cells from Dormancy
  124. Activating transcription factor 4 increases chemotherapeutics resistance of human hepatocellular carcinoma
  125. Functional Characterization and Expression Profiling of Human Induced Pluripotent Stem Cell- and Embryonic Stem Cell-Derived Endothelial Cells
  126. Novel MicroRNA Prosurvival Cocktail for Improving Engraftment and Function of Cardiac Progenitor Cell Transplantation
  127. Preparation and Evaluation of Magnetic Nanoparticles for Cell Labeling
  128. Bioluminescence reporter gene imaging characterize human embryonic stem cell-derived teratoma formation
  129. Effects of Long-Term Culture on Human Embryonic Stem Cell Aging
  130. MicroRNA-210 as a Novel Therapy for Treatment of Ischemic Heart Disease
  131. Effects of Ionizing Radiation on Self-Renewal and Pluripotency of Human Embryonic Stem Cells
  132. Embryonic Stem Cell–Derived Endothelial Cells Engraft Into the Ischemic Hindlimb and Restore Perfusion
  133. Human Neural Stem Cell Grafts Modify Microglial Response and Enhance Axonal Sprouting in Neonatal Hypoxic–Ischemic Brain Injury
  134. A nonviral minicircle vector for deriving human iPS cells
  135. Functional and Transcriptional Characterization of Human Embryonic Stem Cell-Derived Endothelial Cells for Treatment of Myocardial Infarction
  136. nAChRs Mediate Human Embryonic Stem Cell-Derived Endothelial Cells: Proliferation, Apoptosis, and Angiogenesis
  137. Novel Minicircle Vector for Gene Therapy in Murine Myocardial Infarction
  138. Molecular and Magnetic Resonance Imaging of Human Embryonic Stem Cell–Derived Neural Stem Cell Grafts in Ischemic Rat Brain
  139. Imaging Survival and Function of Transplanted Cardiac Resident Stem Cells
  140. Imaging of STAT3 Signaling Pathway During Mouse Embryonic Stem Cell Differentiation
  141. Transplantation of human embryonic stem cell-derived endothelial cells for vascular diseases
  142. Short Hairpin RNA Interference Therapy for Ischemic Heart Disease
  143. Transcriptome Alteration in the Diabetic Heart by Rosiglitazone: Implications for Cardiovascular Mortality
  144. Comparison of Reporter Gene and Iron Particle Labeling for Tracking Fate of Human Embryonic Stem Cells and Differentiated Endothelial Cells in Living Subjects
  145. Genetic Modification of Embryonic Stem Cells with VEGF Enhances Cell Survival and Improves Cardiac Function
  146. Differentiation, Survival, and Function of Embryonic Stem Cell Derived Endothelial Cells for Ischemic Heart Disease
  147. Positron emission tomography imaging of conditional gene activation in the heart
  148. Molecular Imaging of Embryonic Stem Cell Misbehavior and Suicide Gene Ablation
  149. Quantum dot imaging for embryonic stem cells
  150. Anti-angiogenesis effects of meisoindigo on chronic myelogenous leukemia in vitro
  151. Kinetic expression of platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31) during embryonic stem cell differentiation
  152. Enhancement of neovascularization with cord blood CD133 + cells-derived endothelial progenitor cells transplantation